• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年腹膜癌的细胞减灭术及围手术期腹腔内化疗

Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis in the elderly.

作者信息

Huang Yeqian, Alzahrani Nayef A, Alzahrani Saleh E, Zhao Jing, Liauw Winston, Morris David L

机构信息

St George Clinical School, University of New South Wales, St George Hospital, New South Wales, Australia.

Department of Surgery, University of New South Wales, St George Hospital, New South Wales, Australia.

出版信息

World J Surg Oncol. 2015 Aug 28;13:262. doi: 10.1186/s12957-015-0682-7.

DOI:10.1186/s12957-015-0682-7
PMID:26311565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4551766/
Abstract

BACKGROUND

Peritoneal carcinomatosis is life-threatening without cytoreductive surgery (CRS) and perioperative intraperitoneal chemotherapy (PIC). Only a few studies in the literature addressed the relationship between age and outcomes of peritonectomy. This study was designed to review the clinical outcomes in elderly patients who underwent CRS and PIC.

METHODS

This is a retrospective study of prospectively collected data of 611 consecutive patients with peritoneal carcinomatosis who underwent CRS and PIC by the same surgical team at St George Hospital in Sydney, Australia, between January 1996 and December 2013. Patients were divided into two groups; group 1 (<65 years old, n = 487) and group 2 (≥ 65 years old, n = 124). Subgroup analysis was performed in patients who were ≥75 years old (n = 20). A significant difference was defined as p < 0.05.

RESULTS

There was no significant statistical difference in terms of mean total hospital stay, intensive care unit stay, high dependency unit stay and complication rates. Postoperative mortality was 2 and 3 % in groups 1 and 2, respectively. Overall survival did not reach a statistical significance between the two groups. In subgroup analysis, patients showed similar morbidity results to patients who were <65 years old.

CONCLUSIONS

CRS and PIC can be safely done in the elderly. Age alone should not be the single exclusion criterion but rather taken into consideration along with other factors to determine the suitability of elderly patients.

摘要

背景

腹膜癌若不进行细胞减灭术(CRS)及围手术期腹腔内化疗(PIC)会危及生命。文献中仅有少数研究探讨了年龄与腹膜切除术预后之间的关系。本研究旨在回顾接受CRS和PIC的老年患者的临床结局。

方法

这是一项回顾性研究,对1996年1月至2013年12月期间在澳大利亚悉尼圣乔治医院由同一手术团队连续收治的611例腹膜癌患者的前瞻性收集数据进行分析。患者分为两组;第1组(<65岁,n = 487)和第2组(≥65岁,n = 124)。对年龄≥75岁的患者(n = 20)进行亚组分析。差异有统计学意义定义为p < 0.05。

结果

在平均总住院时间、重症监护病房住院时间、高依赖病房住院时间和并发症发生率方面,无显著统计学差异。第1组和第2组的术后死亡率分别为2%和3%。两组间总生存率未达到统计学意义。在亚组分析中,患者的发病率结果与<65岁的患者相似。

结论

老年患者可安全地进行CRS和PIC。年龄不应单独作为唯一的排除标准,而应与其他因素一起考虑,以确定老年患者的适用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76ea/4551766/cdd485eae728/12957_2015_682_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76ea/4551766/cdd485eae728/12957_2015_682_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76ea/4551766/cdd485eae728/12957_2015_682_Fig1_HTML.jpg

相似文献

1
Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis in the elderly.老年腹膜癌的细胞减灭术及围手术期腹腔内化疗
World J Surg Oncol. 2015 Aug 28;13:262. doi: 10.1186/s12957-015-0682-7.
2
Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center.极限细胞减灭术与热灌注腹腔化疗:来自单一三级中心的结果
Surg Oncol. 2015 Sep;24(3):264-9. doi: 10.1016/j.suronc.2015.06.013. Epub 2015 Jun 23.
3
Is advanced age a hesitation for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in colorectal cancer?高龄是结直肠癌细胞减灭术和腹腔热灌注化疗的犹豫因素吗?
J BUON. 2018 Dec;23(7):77-83.
4
Outcomes of elderly patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal cancer peritoneal carcinomatosis.老年患者行细胞减灭术和围手术期腹腔内化疗治疗结直肠癌腹膜转移的结局。
J Surg Oncol. 2012 Feb;105(2):113-8. doi: 10.1002/jso.22019. Epub 2011 Jul 20.
5
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in Asian patients: 100 consecutive patients in a single institution.亚洲患者的细胞减灭术和腹腔内热化疗:单机构 100 例连续患者。
Ann Surg Oncol. 2013 Sep;20(9):2968-74. doi: 10.1245/s10434-013-2947-0. Epub 2013 Mar 17.
6
Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi-institutional experience.结直肠癌腹膜转移患者接受或不接受腹腔热灌注化疗的反复减瘤手术:一项多机构经验。
J Surg Oncol. 2019 Mar;119(3):336-346. doi: 10.1002/jso.25277. Epub 2018 Dec 16.
7
Morbidity and mortality outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients aged 75 years and over: Spanish group of peritoneal cancer surgery (GECOP) multicenter study.75岁及以上患者接受细胞减灭术和腹腔内热灌注化疗后的发病和死亡结局:西班牙腹膜癌手术组(GECOP)多中心研究
Surg Oncol. 2016 Jun;25(2):111-6. doi: 10.1016/j.suronc.2016.03.007. Epub 2016 Apr 4.
8
Extent of colorectal peritoneal carcinomatosis: attempt to define a threshold above which HIPEC does not offer survival benefit: a comparative study.结直肠癌腹膜转移癌的范围:试图确定一个阈值,高于该阈值时腹腔内热灌注化疗(HIPEC)无生存获益:一项比较研究
Ann Surg Oncol. 2015 Sep;22(9):2958-64. doi: 10.1245/s10434-015-4387-5. Epub 2015 Jan 29.
9
More Synchronous Peritoneal Disease but Longer Survival in Younger Patients with Carcinomatosis from Colorectal Cancer Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.结直肠癌腹膜转移患者行细胞减灭术和腹腔热灌注化疗后,年轻患者同步腹膜疾病更多,但生存时间更长。
Ann Surg Oncol. 2019 Mar;26(3):845-851. doi: 10.1245/s10434-018-07087-9. Epub 2019 Jan 14.
10
Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.细胞减灭术和腹腔内热灌注化疗后高级别阑尾或结直肠腹膜癌转移进展的预测因素
Ann Surg Oncol. 2015 May;22(5):1716-21. doi: 10.1245/s10434-014-3985-y. Epub 2014 Aug 22.

引用本文的文献

1
Overall survival and morbidity are not associated with advanced age for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a single centre experience.对于减瘤手术和腹腔内热灌注化疗而言,总体生存率和发病率与高龄无关:一项单中心经验。
Pleura Peritoneum. 2023 Apr 11;8(2):83-90. doi: 10.1515/pp-2022-0202. eCollection 2023 Jun.
2
Quality Standards for Surgery of Colorectal Peritoneal Metastasis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.减瘤手术与热灌注化疗后结直肠腹膜转移瘤手术的质量标准
Ann Surg Oncol. 2022 Jan;29(1):188-202. doi: 10.1245/s10434-021-10642-6. Epub 2021 Aug 25.

本文引用的文献

1
Cytoreductive surgery and HIPEC for peritoneal carcinomatosis in the elderly.老年腹膜癌的细胞减灭术和腹腔热灌注化疗
Int J Surg Oncol. 2014;2014:987475. doi: 10.1155/2014/987475.
2
Outcomes of Cytoreductive Surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients older than 70 years; survival benefit at considerable morbidity and mortality.70 岁以上患者行细胞减灭术(CRS)联合腹腔内热灌注化疗(HIPEC)的疗效;高发病率和死亡率下的生存获益。
Ann Surg Oncol. 2013 Oct;20(11):3497-503. doi: 10.1245/s10434-013-3053-z. Epub 2013 Jun 19.
3
Comparative analysis of perioperative intraperitoneal chemotherapy regimen in appendiceal and colorectal peritoneal carcinomatosis.
比较分析阑尾和结直肠腹膜转移癌围手术期腹腔内化疗方案。
Int J Clin Oncol. 2013 Jun;18(3):439-46. doi: 10.1007/s10147-012-0397-5. Epub 2012 Mar 14.
4
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in elderly patients.老年患者的细胞减灭术加腹腔内热化疗。
In Vivo. 2011 Jul-Aug;25(4):687-90.
5
Peritoneal carcinomatosis cytoreductive surgery and HIPEC: a ray of hope for cure.腹膜癌减瘤手术及腹腔热灌注化疗:治愈的一线希望
Hepatogastroenterology. 2010 Sep-Oct;57(102-103):1173-7.
6
Evaluation of the cost-effectiveness of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (peritonectomy) at the St George Hospital peritoneal surface malignancy program.圣乔治医院腹膜表面恶性肿瘤项目中细胞减灭术和腹腔热灌注化疗(腹膜切除术)的成本效益评价。
Ann Surg. 2010 Feb;251(2):323-9. doi: 10.1097/SLA.0b013e3181c9b53c.
7
Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality.减瘤手术联合腹腔内热灌注化疗治疗腹膜癌病是否仍应被视为高风险手术?:一项关于发病率和死亡率的系统评价
Ann Surg. 2009 Jun;249(6):900-7. doi: 10.1097/SLA.0b013e3181a45d86.
8
Cytoreductive surgery in the elderly patients--is it feasible?老年患者的肿瘤细胞减灭术——可行吗?
Hepatogastroenterology. 2008 Nov-Dec;55(88):2005-11.
9
Lessons learned from initial experience with peritonectomy and intra-peritoneal chemotherapy infusion.从腹膜切除及腹腔化疗灌注的初步经验中获得的教训。
World J Surg. 2006 Dec;30(12):2132-5. doi: 10.1007/s00268-005-0474-2.
10
Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.手术并发症的分类:一项在6336例患者队列中进行评估的新提议及一项调查结果
Ann Surg. 2004 Aug;240(2):205-13. doi: 10.1097/01.sla.0000133083.54934.ae.